Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04061447
Status:
COMPLETED
Last Update Posted:
2019-08-20
First Post:
2019-08-16
Brief Title:
Tailored Juice-guided Eradication Therapy
Sponsor:
Kaohsiung Medical University
Organization:
Kaohsiung Medical University
Study Overview
Official Title:
Tailored Antibiotic Susceptibility-guided Therapy Via Gastric Juice PCR for First-line H Pylori Eradication a Prospective Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HP
Brief Summary:
In this study the investigators aim to investigate the efficacy of tailored anti-microbial susceptibility guided-therapy via gastric juice PCR compared with empirical standard triple therapy
Detailed Description:
The eradication of H pylori is an important clinical issue due to its association with many gastrointestinal diseases such as peptic ulcer and even gastric cancer However with the global trend of increasing antibiotic resistance the eradication rate of clarithromycin-based standard triple therapy has declined to less than 80 To overcome such alarming antibiotic resistance antimicrobial susceptibility-guided therapy is recommended However the literature on gastric juice PCR as susceptibility-guided therapy is scant therefore the investigators conducted this prospective randomized controlled trial with the aim of investigating the efficacy of antibiotic susceptibility-guided therapy via gastric juice PCR for first-line eradication
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None